Medication Adherence and its Related Factors in Patients Undergoing Coronary Artery Angioplasty

Arsalan Salari1, Leila Rouhi Balasi2, Asieh Ashouri3

  • 1Department of Cardiology, Cardiovascular Diseases Research Center, Heshmat Hospital, Faculty of Medicine, Guilan University of Medical Sciences, Rasht, Iran.

Insights

Medication adherence is crucial after Percutaneous Coronary Intervention (PCI) to prevent coronary artery disease (CAD) recurrence. A study found 28% of PCI patients non-adherent, highlighting the need for cardiac rehabilitation programs.

Area of Science:

  • Cardiology
  • Public Health
  • Health Psychology

Background:

  • Percutaneous Coronary Intervention (PCI) does not halt coronary artery atherosclerosis.
  • Preventing recurrent cardiac events post-PCI necessitates modifying risk factors and adhering to drug therapies.
  • Medication adherence is a significant challenge in healthcare systems for post-PCI patients.

Purpose of the Study:

  • To determine medication adherence rates among patients who underwent PCI.
  • To identify factors associated with medication adherence in this patient group.

Main Methods:

  • A cross-sectional study was conducted with 269 patients undergoing PCI at Dr. Heshmat hospital in Rasht, Iran.
  • Data were collected using a questionnaire assessing socio-individual factors, medication adherence (Morisky scale), anxiety/depression (HADS), and self-efficacy.
  • Statistical analysis included descriptive statistics and multivariable logistic regression.

Main Results:

  • 28% of patients (75 out of 269) demonstrated non-adherence to their prescribed medications.
  • A majority experienced clinical anxiety (44.2%) and mild depression (55.8%).
  • Spouse's educational level and a family history of coronary artery disease were significant predictors of medication adherence.

Conclusions:

  • Incomplete medication adherence is prevalent among post-PCI patients.
  • The findings emphasize the critical need for robust cardiac rehabilitation systems.
  • Establishing cardiac rehabilitation centers is recommended to improve patient outcomes.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
428
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
323
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
369
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
686